GLP1 Receptor Agonists-Effects beyond Obesity and Diabetes
The antibodies used for the immunoblot assays were: GCLC (Santa Cruz Biotech, #sc-390811), NQO1 (Sigma Prestige Antibodies, HPA007308), ACTIN (Sigma, A1978), NRF2 (Cell Signaling Technology, #12721), NRF1 (Cell Signaling Technology, #8052), YAP/TAZ (Cell Signaling, #8418) 4-HNE (Abcam, #ab46545) and Lamin A/C (Cell Signaling, #4777)
A 2022 meta-analysis in Frontiers in Nutrition analyzed 49 studies of berberine supplementation lasting four to 104 weeks in adults, aged 25 to 65 on average
Anxiety Reduction: Preliminary research also suggests that GLP-1 inhibitors might help alleviate anxiety symptoms